The Antibiotic Resistance Reservoir
Directing the Affinity of Monoclonal Antibodies
Match-Making Peptides with Small Molecules
GPCR FlAsH-Walk Mapping: A Leap into the Future
Predicting the Unpredictable
Shining a Light on Psychiatric Disorders
Opportunities for Pan-Spectrum Drugs against Herpes
Breakthrough Discovery in Diabetes
Illuminating the Life of GPCRs
Towards Fast Discovery of New Vaccines
Breathing Space: Biomarkers in Pulmonary Hypertension

A promising projects portfolio

As of today, CQDM has 59 outstanding research projects for a total of $ 43 M invested. These projects are carried out by a network of 902 researchers, including 169 graduate and post-graduate students, from 74 research institutions (40 public and 34 private) in Quebec, Canada and internationally. These projects cut across 120 mentors from CQDM’s pharmaceutical companies members.

completed projects